Clinical Trials Directory

Trials / Completed

CompletedNCT02621307

Effect of Salba & Flax on Postprandial Glycemia and Subjective Satiety

The Effect of Salba (Salvia Hispanica L) Versus Flax on Postprandial Blood Glucose Response and Subjective Appetite in Healthy Individuals

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Unity Health Toronto · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether drinks containing Salvia hispanica L (Salba) or Flax lower postprandial blood glucose levels and improve appetite in healthy individuals.

Detailed description

Dietary fibre has been implicated in improving many risk factors associated with Type 2 Diabetes and Cardiovascular Disease (CVD). However, on average, Norther Americans consume less than half of the recommended amount set by health agencies. It has been proposed that the health benefits of dietary fibre may be attritbuted to rheological characteristics such as viscosity. Salvia hispanica L (Salba) and Flax are nutritionally similar. The primary objective of this research trial is to study the effects of Salba and Flax on postprandial glycemia and appetite in healthy individuals.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSalba
DIETARY_SUPPLEMENTFlax
DIETARY_SUPPLEMENTControl

Timeline

Start date
2010-07-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2015-12-03
Last updated
2015-12-03

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02621307. Inclusion in this directory is not an endorsement.